Jonathan J. Miner

Rheumatology

3400 Civic Center Boulevard
South Pavilion, 1st Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 65 publications

Autoinflammatory syndromes of STING and TREX1 dysfunction.

Autoinflammatory syndromes of STING and TREX1 dysfunction.

Journal: The Journal of clinical investigation

Published: June 01, 2026

CD14-deficiency protects against osteoarthritic subchondral bone sclerosis via enhanced osteoclastogenesis following joint injury.

CD14-deficiency protects against osteoarthritic subchondral bone sclerosis via enhanced osteoclastogenesis following joint injury.

Journal: bioRxiv : the preprint server for biology

Published: February 23, 2026

Neuroimaging Biomarkers of Disease Progression and Cognitive Change in Patients With Retinal Vasculopathy With Cerebral Leukoencephalopathy.

Neuroimaging Biomarkers of Disease Progression and Cognitive Change in Patients With Retinal Vasculopathy With Cerebral Leukoencephalopathy.

Journal: Neurology

Published: February 20, 2026

Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.

Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage.

Journal: Circulation

Published: December 11, 2025

Drosophila melanogaster model of RVCL-S demonstrates age dependent disease progression.

Drosophila melanogaster model of RVCL-S demonstrates age dependent disease progression.

Journal: bioRxiv : the preprint server for biology

Published: November 26, 2025

Adult-onset STING-associated vasculopathy.

Adult-onset STING-associated vasculopathy.

Journal: Journal of human immunity

Published: November 04, 2025

Longitudinal association of retinal morphology and white matter progression in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Longitudinal association of retinal morphology and white matter progression in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Journal: Frontiers in neurology

Published: October 13, 2025

The intersection of TREX1, cGAS, STING and the DNA damage theory of aging.

The intersection of TREX1, cGAS, STING and the DNA damage theory of aging.

Journal: Frontiers in aging

Published: October 07, 2025

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study.

Journal: The Journal of clinical investigation

Published: December 16, 2024

Multi-stage-mixing to control the supramolecular structure of lipid nanoparticles, thereby creating a core-then-shell arrangement that improves performance by orders of magnitude.

Multi-stage-mixing to control the supramolecular structure of lipid nanoparticles, thereby creating a core-then-shell arrangement that improves performance by orders of magnitude.

Journal: bioRxiv : the preprint server for biology

Published: November 28, 2024

The prototypical interferonopathy: Aicardi-Goutières syndrome from bedside to bench.

The prototypical interferonopathy: Aicardi-Goutières syndrome from bedside to bench.

Journal: Immunological reviews

Published: October 30, 2024

Prime Editor Gene Therapy and TREX1 Mosaicism in Retinal Vasculopathy with Cerebral Leukoencephalopathy.

Prime Editor Gene Therapy and TREX1 Mosaicism in Retinal Vasculopathy with Cerebral Leukoencephalopathy.

Journal: Journal of clinical immunology

Published: September 17, 2024

Showing 1-12 of 65

Last Updated: 09/26/2026